Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Market Cap

Stoke Therapeutics has a market cap or net worth of $583.42 million as of April 23, 2024. Its market cap has increased by 61.75% in one year.

• Market Cap: 583.42M
• Enterprise Value: 386.64M
• 1-Year Change: 61.75%
• Ranking: #2822
• Category: Small-Cap
• Stock Price: $11.25

Market Cap Chart

Since June 19, 2019, Stoke Therapeutics's market cap has decreased from $774.00M to $583.42M, a decrease of -24.62%. That is a compound annual growth rate of -5.67%.

Market Cap History

Date	Market Cap	% Change
Apr 22, 2024	520.90M	-6.65%
Apr 19, 2024	558.00M	3.45%
Apr 18, 2024	539.40M	-0.61%
Apr 17, 2024	542.70M	-5.86%
Apr 16, 2024	576.50M	1.96%
Apr 15, 2024	565.40M	-4.38%
Apr 12, 2024	591.30M	-5.41%
Apr 11, 2024	625.10M	5.81%
Apr 10, 2024	590.80M	-0.71%
Apr 9, 2024	595.00M	-1.15%
Apr 8, 2024	601.90M	3.42%
Apr 5, 2024	582.00M	3.28%
Apr 4, 2024	563.50M	-5.04%
Apr 3, 2024	593.40M	-2.03%
Apr 2, 2024	605.70M	-3.03%
Apr 1, 2024	624.60M	-0.08%
Mar 28, 2024	625.10M	-4.72%
Mar 27, 2024	656.10M	37.69%
Mar 26, 2024	476.50M	58.31%
Mar 25, 2024	301.00M	7.00%
Mar 22, 2024	281.30M	5.16%
Mar 21, 2024	267.50M	-
Mar 20, 2024	267.50M	3.28%
Mar 19, 2024	259.00M	-4.60%
Mar 18, 2024	271.50M	-4.84%

View and export this data all the way back to 2019. Sign Up Today.

Related Stocks

Company	Market Cap
SIGA Technologies	593.61M
Wave Life Sciences	591.85M
Cross Country Healthcare	591.03M
ORIC Pharmaceuticals	587.52M
Nuvation Bio	584.36M
Allogene Therapeutics	574.91M
Prime Medicine	573.31M
Novavax	569.61M